Orchestra BioMed Holdings OBIO
NASDAQ OBIO
$5.09 +0.35 (+7.27%)
As of: Sep 4, 2026 · 3:20 PM EDT

Orchestra BioMed Holdings (OBIO) Shares Outstanding (Diluted) (2021 - 2026)

Analysis

Orchestra BioMed Holdings (OBIO) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn 66.03 Mn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn - 210.89 Mn
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 115.80 Mn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 138.28 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 556.90 Mn
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn 217.35 Mn
10 Orchestra BioMed Holdings 324.80 Mn 130.27 Mn 63,000.00 63.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63.81 Mn
Mar 31, 2026 62.72 Mn
Dec 31, 2025 47.75 Mn
Sep 30, 2025 52.19 Mn
Jun 30, 2025 38.39 Mn
Mar 31, 2025 38.24 Mn
Dec 31, 2024 36.82 Mn
Sep 30, 2024 37.62 Mn
Jun 30, 2024 35.80 Mn
Mar 31, 2024 35.78 Mn
Dec 31, 2023 33.23 Mn
Sep 30, 2023 35.24 Mn
Jun 30, 2023 34.61 Mn
Mar 31, 2023 27.64 Mn
Dec 31, 2022 16.43 Mn
Sep 30, 2022 13.72 Mn
Jun 30, 2022 20.45 Mn
Mar 31, 2022 9.23 Mn
Dec 31, 2021 20.45 Mn
Sep 30, 2021 20.45 Mn